We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
Cap. Flow
-$587M
Cap. Flow %
-4.35%
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38

Top Buys

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$30.1M
2
ET icon
Energy Transfer Partners
ET
+$24.7M
3
FLJP icon
Franklin FTSE Japan ETF
FLJP
+$11.8M
4
WFC icon
Wells Fargo
WFC
+$9.66M
5
ALKS icon
Alkermes
ALKS
+$8.97M

Sector Composition

Rank Sector Weight
1 Energy 65.41%
2 Financials 7.05%
3 Healthcare 3.6%
4 Consumer Discretionary 3.1%
5 Technology 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LII icon
301
Lennox International
LII
$18.8B
$1.14M 0.01%
4,132
-760
-16% -$207K
CCXI
302
DELISTED
ChemoCentryx, Inc.
CCXI
$1.13M 0.01%
121,493
-546
-0.4% -$6.32K
ROK icon
303
Rockwell Automation
ROK
$51.4B
$1.13M 0.01%
6,871
-5,498
-44% -$929K
LRCX icon
304
Lam Research
LRCX
$382B
$1.12M 0.01%
59,410
-2,960
-5% -$56.2K
NVR icon
305
NVR
NVR
$17.2B
$1.11M 0.01%
329
-71
-18% -$228K
VOE icon
306
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$1.11M 0.01%
9,939
+159
+2% +$17.4K
CSX icon
307
CSX Corp
CSX
$98.6B
$1.1M 0.01%
42,621
-7,596
-15% -$196K
SWKS icon
308
Skyworks Solutions
SWKS
$9.06B
$1.1M 0.01%
14,200
+2,729
+24% +$216K
PGNX
309
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.09M 0.01%
177,379
-26,824
-13% -$129K
SPWR
310
DELISTED
SunPower Corporation Common Stock
SPWR
$1.09M 0.01%
155,607
+78,979
+103% +$420K
QLYS icon
311
Qualys
QLYS
$4.84B
$1.09M 0.01%
12,492
+1,491
+14% +$129K
NSC icon
312
Norfolk Southern
NSC
$78.8B
$1.08M 0.01%
5,445
-1,363
-20% -$270K
CL icon
313
Colgate-Palmolive
CL
$72.6B
$1.08M 0.01%
15,124
-960
-6% -$68.1K
O icon
314
Realty Income
O
$61.2B
$1.08M 0.01%
16,193
-998
-6% -$68.2K
DUK icon
315
Duke Energy
DUK
$102B
$1.08M 0.01%
12,250
-926
-7% -$81.8K
CBIO
316
Crescent Biopharma
CBIO
$602M
$1.08M 0.01%
904
-138
-13% -$165K
FTNT icon
317
Fortinet
FTNT
$112B
$1.06M 0.01%
68,960
+12,830
+23% +$211K
INTC icon
318
Intel
INTC
$466B
$1.05M 0.01%
21,885
+12,811
+141% +$635K
SVC
319
Service Properties Trust
SVC
$1.1B
$1.05M 0.01%
8,385
+422
+5% +$54.1K
ALGN icon
320
Align Technology
ALGN
$12B
$1.03M 0.01%
3,778
-92
-2% -$27.8K
BLDP
321
Ballard Power Systems
BLDP
$874M
$1.03M 0.01%
252,543
+126,321
+100% +$457K
BXP icon
322
Boston Properties
BXP
$11B
$1.03M 0.01%
7,984
-731
-8% -$98.2K
ZION icon
323
Zions Bancorporation
ZION
$10.1B
$1.03M 0.01%
22,402
-696
-3% -$32.2K
PBYI icon
324
Puma Biotechnology
PBYI
$406M
$1.03M 0.01%
+80,800
New +$1.86M
PARA
325
DELISTED
Paramount Global Class B
PARA
$1.02M 0.01%
20,519
-8,128
-28% -$402K

Similar funds

ALPS Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.

  • ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
  • ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
  • ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
  • ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
  • ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
  • ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
  • ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.